Internal Medicine, Hematology & Oncology · Huntersville, NC
NPI
1700897121
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9930 Kincey Ave Ste 165
Huntersville, NC, 28078
Phone (704) 947-5005
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
67,254 services
Medicare patients, 2024
290
Average age 74
Drug cost, 2024
$4.7M
1,134 prescriptions
Company payments, 2025
$6,877
From 52 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jack Burton was code J1439 (injection, ferric carboxymaltose, 1 mg), 12,750 times for 12 patients. In total Jack Burton billed 67,254 services in 123 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 12,750 | 12 | $0.87 | $11K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,725 | 25 | $0.10 | $263 |
| J0897 Injection, denosumab, 1 mg | Office | 2,101 | 18 | $20.69 | $43K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 17 | $15.27 | $29K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,502 | 52 | $0.09 | $135 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,360 | 11 | $5.41 | $7,354 |
| 85025 Blood Count | Office | 773 | 232 | $7.56 | $5,846 |
| 80053 Clinical Chemistry | Office | 753 | 231 | $10.34 | $7,784 |
| 36415 Venipuncture Blood Collection | Office | 632 | 218 | $7.62 | $4,813 |
| 83615 Clinical Chemistry | Office | 615 | 209 | $5.90 | $3,629 |
| 96372 Injection Administration | Office | 553 | 105 | $9.51 | $5,257 |
| 82728 Clinical Chemistry | Office | 529 | 188 | $13.34 | $7,055 |
| 82784 Immunoassay | Office | 468 | 53 | $9.11 | $4,265 |
| 85045 Blood Count | Office | 455 | 174 | $3.89 | $1,772 |
| 96367 Intravenous Infusion, Hydration | Office | 438 | 52 | $20.37 | $8,924 |
By year: 2022 $1.9M for 75,261 services; 2023 $1.5M for 62,315 services; 2024 $1.1M for 67,254 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 773 | 232 | $7.56 | $5,846 |
| 80053 Clinical Chemistry | 753 | 231 | $10.34 | $7,784 |
| 36415 Venipuncture Blood Collection | 632 | 218 | $7.62 | $4,813 |
| 83615 Clinical Chemistry | 615 | 209 | $5.90 | $3,629 |
| 82728 Clinical Chemistry | 529 | 188 | $13.34 | $7,055 |
| 82784 Immunoassay | 468 | 53 | $9.11 | $4,265 |
| 85045 Blood Count | 455 | 174 | $3.89 | $1,772 |
| 83550 Clinical Chemistry | 344 | 117 | $8.47 | $2,915 |
| 82607 Clinical Chemistry | 342 | 181 | $14.70 | $5,027 |
| 83540 Clinical Chemistry | 321 | 113 | $6.32 | $2,029 |
Medicare prescription drug claims, 2024
In 2024, the drug Jack Burton prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 189 prescriptions and refills. In total Jack Burton wrote 1,134 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 189 | 189 | 21 | $242K |
| Xarelto Rivaroxaban | 72 | 100 | 18 | $56K |
| Eliquis Apixaban | 59 | 85 | 14 | $49K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 41 | 41 | Under 11 | $334K |
| Fulvestrant Generic | 29 | 29 | Under 11 | $9,765 |
| Ibrance Palbociclib | 27 | 27 | Under 11 | $420K |
| Mirtazapine Generic | 27 | 29 | Under 11 | $210 |
| Calquence Acalabrutinib Maleate | 22 | 22 | Under 11 | $313K |
| Abiraterone Acetate Generic | 22 | 22 | Under 11 | $89K |
| Potassium Chloride Generic | 21 | 35 | Under 11 | $199 |
| Bexarotene Generic | 21 | 22 | Under 11 | $26K |
| Hydroxyurea Generic | 21 | 35 | Under 11 | $456 |
| Pomalyst Pomalidomide | 20 | 20 | Under 11 | $330K |
| Brukinsa Zanubrutinib | 20 | 20 | Under 11 | $296K |
| Dexamethasone Generic | 18 | 18 | Under 11 | $266 |
Brand drugs: 689 claims; generic drugs: 445 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jack Burton $6,877 ($6,877 in general payments such as food, travel and fees) from 52 companies. The largest payer was Geron Corporation with $2,877.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 6 | $2,877 |
| Janssen Biotech, Inc. JNJ | 10 | $312 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $282 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $266 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $223 |
| Pfizer Inc. PFE | 10 | $214 |
| Daiichi Sankyo Inc. 4568.T | 6 | $150 |
| Merck Sharp & Dohme LLC MRK | 5 | $144 |
| Genentech USA, Inc. ROG.SW | 5 | $143 |
| Exelixis Inc. EXEL | 6 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.